Incyte Corporation Profile Avatar - Palmy Investing

Incyte Corporation

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and p…

Biotechnology
US, Wilmington [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Incyte Corporation (INCY) to it's peer group.

Peer Group
Loading...
End of INCY's Analysis
CIK: 879169 CUSIP: 45337C102 ISIN: US45337C1027 LEI: - UEI: -
Secondary Listings
INCY has no secondary listings inside our databases.